NCT06257550Completed
AdapTive Personalized Dietitian coacHing, Messaging and pRoduce prescrIption to improVE Healthy Dietary Behaviors
THRIVE: AdapTive Personalized Dietitian coacHing, Messaging and pRoduce prescrIption to improVE Healthy Dietary Behaviors
Source: ClinicalTrials.gov · Last updated 5 Nov 2025
Brief summary (registry, in English)
THRIVE intervention is a 2-arm randomized pilot trial testing the feasibility and preliminary efficacy of producing prescriptions, tailored dietitian counseling with adaptive messages, and linkages to social resources among 80 Black adults with hypertension.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 5 Feb 2024
- Start date
- 10 Jun 2024
- Primary completion date
- 20 Oct 2025
- Lead sponsor
- Johns Hopkins University
- Diseases
- High blood pressure
- NCT number
- NCT06257550
What you commit to
- Study type: Interventional
- Participants enrolled: 80
- From 10 Jun 2024 to the primary completion date, 20 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of end-stage renal disease (ESRD)
- Condition which interferes with outcome measurement (e.g., dialysis)
- Serious medical condition which either limits life expectancy or requires active management (e.g. cancer)
- Significant food allergies, preferences, intolerances, or dietary requirements that would interfere with diet adherence
- Patients with cognitive impairment or other condition preventing their participation in the intervention
- Current participation in a care management program related to health conditions (e.g., weight reduction, smoking cessation)
- Other conditions or situations at the discretion of the Investigative team
Lab values
- Type 1 or Type 2 Diabetes defined as a hemoglobin A1c ≥6.5% or diabetes treatment
Age
- Age \<18 years
Other
- Current participation in another clinical trial that could interfere with the study protocol
- Those planning to move out of the geographic area in 12 months
- Unwillingness to provide informed consent
Who the study is looking for
- 18 years or older
- Self-identify as Black/African American
- Have diagnosed hypertension stages 1 (130-139/80-89 mm Hg) OR 2 (\>140/90 mm Hg), determined via self-report and/or Electronic Medical Records (EMR)
- Live in census tracts identified by Montgomery County Department of Planning as HFPA:
- Healthy Food Availability Index score is low (0-9.5),
- Median household income ≤185% of Federal Poverty Level
- \>30% households have no vehicle, Distance to supermarket \>1/4 mile.
- Participants must have refrigeration, food appliances (microwave, stove),
- Cell phone to receive messages
Age in the registry: 18 years to 79 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johns Hopkins University Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.